Terms: = Head and neck cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
2456 results:
1. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract] [Full Text] [Related]
2. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
3. Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
Chen Y; Huang Y; Chen X; Chen Z; Peng X; Lin S; Lin C; Zong J
BMC Cancer; 2024 Apr; 24(1):483. PubMed ID: 38627711
[TBL] [Abstract] [Full Text] [Related]
4. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
5. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
6. Impact of sarcopenia on overall survival and local relapse in head and neck cancer patients undergoing surgical excision.
Duymaz YK; Topcuoglu ED; Sahin S; Kucuk F; Erkmen B
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2161-2167. PubMed ID: 38567578
[TBL] [Abstract] [Full Text] [Related]
7. How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.
Ferrari M; Mularoni F; Taboni S; Crosetti E; Pessina C; Carobbio ALC; Montalto N; Marchi F; Vural A; Paderno A; Caprioli S; Gaudioso P; Fermi M; Rigoni F; Saccardo T; Contro G; Ruaro A; Lo Manto A; Varago C; Baldovin M; Bandolin L; Filauro M; Sampieri C; Missale F; Ioppi A; Carta F; Ramanzin M; Ravanelli M; Maiolo V; Bertotto I; Del Bon F; Lancini D; Mariani C; Marrosu V; Tatti M; Cağlı S; Yüce I; Gündoğ M; Dogan S; Anile G; Gottardi C; Busato F; Vallin A; Gennarini F; Bossi P; Ghi MG; Lionello M; Zanoletti E; Marioni G; Maroldi R; Mattioli F; Puxeddu R; Bertolin A; Presutti L; Piazza C; Succo G; Peretti G; Nicolai P
Oral Oncol; 2024 May; 152():106744. PubMed ID: 38520756
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.
Struckmeier AK; Buchbender M; Lutz R; Agaimy A; Kesting M
Head Neck; 2024 May; 46(5):1083-1093. PubMed ID: 38501325
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Qian T; Liu D; Cao G; Chen Z; Zhang Q
Technol Cancer Res Treat; 2024; 23():15330338241231610. PubMed ID: 38497137
[TBL] [Abstract] [Full Text] [Related]
10. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
Ding C; Dai DY; Luo ZK; Wang GY; Dong Z; Qin GJ; Du XJ; Ma J
Oral Oncol; 2024 Apr; 151():106725. PubMed ID: 38430711
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
[TBL] [Abstract] [Full Text] [Related]
13. Risk stratification of LA-NPC during chemoradiotherapy based on clinical classification and TVRR.
Tang Q; Mei C; Huang B; Huang R; Kang L; Chen A; Lei N; Deng P; Ying S; Zhang P; Qin Y
Cancer Med; 2024 Feb; 13(3):e7029. PubMed ID: 38396378
[TBL] [Abstract] [Full Text] [Related]
14. [Repairing partial suprahyoid epiglottis-preserved circumferential defect in near total laryngectomy with anterior medial thigh flap in advanced laryngeal cancer].
Yang L; Li W; Zheng Y; Ji L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Feb; 38(2):133-139. PubMed ID: 38385223
[TBL] [Abstract] [Full Text] [Related]
15. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract] [Full Text] [Related]
16. Discrepancy between clinical and pathological staging of laryngeal carcinoma: a dilemma to be solved.
Tawfik A; El-Fattah AMA; Hassan A; Helal FA; Ebada HA
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2507-2513. PubMed ID: 38345614
[TBL] [Abstract] [Full Text] [Related]
17. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
18. The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology.
Croce L; Teliti M; Chytiris S; Sparano C; Coperchini F; Villani L; Calì B; Petrone L; Magri F; Trimboli P; Rotondi M
Eur J Endocrinol; 2024 Feb; 190(2):165-172. PubMed ID: 38298148
[TBL] [Abstract] [Full Text] [Related]
19. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
Xie L; Zhang Z
Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
[TBL] [Abstract] [Full Text] [Related]
20. Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio.
Mahmoud W; Hassoun L; Kerbage A; Mukherji D; Shamseddine A; Tamraz S; Hakim A; Barada K
BMC Gastroenterol; 2024 Jan; 24(1):27. PubMed ID: 38195445
[TBL] [Abstract] [Full Text] [Related]
[Next]
